← Back to headlines
Morgan Stanley Downgrades Smith & Nephew on Guidance Concerns
Investment bank Morgan Stanley has lowered its stock rating for medical device maker Smith & Nephew, citing worries over the company's future earnings guidance.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
